KUALA LUMPUR, Oct 2 (Bernama) -- Dyadic International Inc (Dyadic), a global biotechnology company has announced its management will be presenting at the industry and investor events during the month of October.
The first event of the month, namely, Enzyme Engineering XXVII will take place from Oct 1 to 6 in Park Royale Hotel, Singapore with presentation by Dyadic Chief Scientific Officer, Dr Ronen Tchelet on the Oct 4.
It will be followed by LD Mirco Main Event XVI (Oct 3-5), in Luxe Sunset Blvd Hotel, Los Angeles, which will be presented by its President and Chief Executive Officer, Mark Emalfarb on Oct 4.
Additionally, Emalfarb will also be presenting at World Vaccine Congress Europe (Oct 16-19), in Fira de Barcelona Montjuic, Barcelona, Spain on Oct 18, according to a statement.
Dyadic focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness.
With a passion to enable its partners and collaborators to develop effective preventative and therapeutic treatments in both developed and emerging countries, Dyadic is building an active pipeline by advancing its proprietary microbial platform technologies.
-- BERNAMA
No comments:
Post a Comment